1.
Ann Pharmacother
; 29(2): 187-8, 1995 Feb.
Article
in English
| MEDLINE
| ID: mdl-7756720
ABSTRACT
Because of both an absence of sufficient data and the concern for increased toxicity in certain patient populations, the use of CCBs to reduce radiocontrast-associated nephrotoxicity is not recommended. Additional prospective, randomized trials are needed.
